Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
IDH1 mutation + NTRK3 fusion
i
Other names:
HEL-216, HEL-S-26, Epididymis Luminal Protein 216, Isocitrate Dehydrogenase 1 (NADP+), Epididymis Secretory Protein Li 26, IDH1, Isocitrate Dehydrogenase (NADP(+)) 1, Isocitrate Dehydrogenase 1 (NADP+), Soluble, NTRK3, TRKC, Neurotrophic tyrosine kinase, receptor, type 3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3417
;
4916
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
IDH1 mutation + Chr del(1p) + Chr del(19q) (10)
IDH1 mutation + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)
IDH1 mutation + NTRK1 fusion (2)
IDH1 mutation + NTRK2 fusion (2)
MYC overexpression + IDH1 mutation (2)
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)
IDH2 mutation + NTRK3 fusion (2)
IDH wild-type + FGFR3 S249C + TP53 V73fs (1)
IDH1 R132S + H3K27me3 loss + MET exon 14 skipping mutation (1)
IDH1 mutation + ATRX deletion + TP53 deletion (1)
IDH1 mutation + FGFR2 fusion (1)
IDH1 mutation + FGFR2 rearrangement (1)
IDH1 mutation + MGMT promoter methylation (1)
IDH1 mutation + MYC amplification + MAPRE1 overexpression (1)
IDH1 mutation + TMB-L (1)
IDH1 mutation + WT1 overexpression (1)
MSI-H/dMMR + NTRK3 fusion (1)
NTRK3 mutation + TMB-H (1)
IDH1 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)
IDH1 mutation + Chr del(1p) + Chr del(19q) (10)
IDH1 mutation + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)
IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)
IDH1 mutation + NTRK1 fusion (2)
IDH1 mutation + NTRK2 fusion (2)
MYC overexpression + IDH1 mutation (2)
IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)
IDH2 mutation + NTRK3 fusion (2)
IDH wild-type + FGFR3 S249C + TP53 V73fs (1)
IDH1 R132S + H3K27me3 loss + MET exon 14 skipping mutation (1)
IDH1 mutation + ATRX deletion + TP53 deletion (1)
IDH1 mutation + FGFR2 fusion (1)
IDH1 mutation + FGFR2 rearrangement (1)
IDH1 mutation + MGMT promoter methylation (1)
IDH1 mutation + MYC amplification + MAPRE1 overexpression (1)
IDH1 mutation + TMB-L (1)
IDH1 mutation + WT1 overexpression (1)
MSI-H/dMMR + NTRK3 fusion (1)
NTRK3 mutation + TMB-H (1)
IDH1 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
IDH1 mutation + NTRK3 fusion
Astrocytoma
IDH1 mutation + NTRK3 fusion
Astrocytoma
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
entrectinib
Sensitive: A2 - Guideline
entrectinib
Sensitive
:
A2
IDH1 mutation + NTRK3 fusion
Astrocytoma
IDH1 mutation + NTRK3 fusion
Astrocytoma
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
larotrectinib
Sensitive: A2 - Guideline
larotrectinib
Sensitive
:
A2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.